Sunil Kumar Joshi

9PUBLICATIONS
50CO-AUTHORS
Molecular targetsHaematologyGlassGene and molecular therapyGranular mechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 10, 2023
The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib.

Sunil K Joshi, Janét Pittsenbarger, Vanessa E Kennedy

|Sep 12, 2023
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.

Christopher A Eide, Stephen E Kurtz, Andy Kaempf

|Feb 03, 2023
Oncoproteomic profiling of AML: moving beyond genomics.

Sunil K Joshi, Cristina E Tognon, Brian J Druker

|Mar 29, 2021
A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistance.

Sunil K Joshi, Setareh Sharzehi, Janét Pittsenbarger

Pageof 2